Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Currently CUDC-907 is in phase I clinical trials for patients with solid tumors or lymphoma
PubMed PMID: 29108673
and 10 mg/kg
It is also an orally active transforming growth factor-β type I receptor inhibitor
21-11+/t26-/m0/s1
Lincomycin Hydrochloride m (dibromide) Currently CUDC-907 is in phaseBisphenol B has a binding affinity for estrogen receptors. Product information CAS Number: 859 18 7 Molecular Weight: 443. 00 Formula: C18H35ClN2O6S Synonym: Lincocin U 10149A U10149A U 10149A Chemical Name: (2S,4R) N [(1R,2R) 2 hydroxy 1 [(2R,3R,4S,5R,6R) 3,4,5 trihydroxy 6 (methylsulfanyl)oxan 2 yl]propyl] 1 methyl 4 propylpyrrolidine 2 carboxamide hydrochloride Smiles: Cl.
US$ 189.00
US$ 189.00
US$ 189.00
US$ 199.00